6th International Bladder Cancer Update

The Westin Kierland Resort and Spa
Scottsdale, Arizona
November 18-20, 2022

ibcu logo white

Overview

The International Bladder Cancer Update (IBCU) is a CME conference focused on the diagnosis and treatment of bladder cancer. The conference offers medical professionals an opportunity to listen to updates from, and interact with, expert international faculty to improve knowledge and determine best treatment practices to improve patient outcomes.

IBCU encompasses expert lectures, interactive discussions, a panel roundtable, debates, and case presentations. It is physician-led, multi-supported, and designed for urologists, urologic oncologists, and other healthcare professionals involved in the treatment of bladder cancer.

Co-Chair

Sam S. Chang, MD, MBA

Sam S. Chang, MD, MBA

Vanderbilt University School of Medicine
Nashville, Tennessee

Co-Chair

Daniel P. Petrylak, MD

Daniel P. Petrylak, MD

Yale Cancer Center
New Haven, Connecticut

Agenda

The 6th International Bladder Cancer Update (IBCU6) offers a robust program that encompasses expert lectures, interactive discussions, a panel roundtable, debates, and case presentations. Join us for the conference, November 18-20, 2022.

This is a working agenda and subject to change. Please check back often for the latest updates.

TimeCourse TitleSpeaker(s)
Friday, November 18, 2022 (ALL TIMES PST)
11:00am – 6:00pmRegistration and Exhibitor Check-in
2:00pm – 6:00pmExhibits Open
3:00pm – 4:00pmIndustry-Supported Educational Symposium
4:00pm – 5:00pmSession I – Bladder Cancer Treatment: An Evolution In ProgressModerator: Seth P. Lerner, MD
4:00pm – 4:10pmWelcome and IntroductionSam S. Chang, MD, MBA
4:10pm – 4:25pmThe Contribution of SWOG to Bladder Cancer Clinical TrialsSeth P. Lerner, MD
4:25pm – 4:40pmAlternative Payment Models - Value Care BundlingC.J. Stimson, MD, JD
4:40pm – 5:00pmPanel Discussion: What Does the Future Hold?Moderator: Sam S. Chang, MD, MBA
5:00pm – 6:00pmIBCU Video Poster Session
6:00pm – 7:00pmIBCU Welcome Reception – Exhibit Hall
7:00pm – 9:00pmFaculty Dinner
EveningOn Own
Saturday, November 19, 2022 (ALL TIMES PST)
7:00am – 8:00amIndustry-supported Educational Breakfast Symposium
7:00am – 12:00pmExhibits Open
8:00am – 11:00amSession II: Management of Non-muscle Invasive BladderModerator: Sam S. Chang, MD, MBA
8:00am – 8:10amWelcome and IntroductionSam S. Chang, MD, MBA
8:10am – 8:30amControversies in NMIBC: Guidelines and BeyondSam S. Chang, MD, MBA
8:30am – 8:50amUse of Biomarkers in NMIBC: What’s New? And What Should We Use?Peter Black, MD
8:50am – 9:10amRisk Stratification: Moving from the Old to the NewJoshua J. Meeks, MD, PhD
9:10am – 9:30amBreak and Visit Exhibits
9:30am – 9:40amPrioritizing the Optimal Therapy for T1 Bladder Cancer: Using the Old and the New To Determine What to DoSeth P. Lerner, MD
9:40pm – 9:50pmPathology of Urothelial CancersDonna Hansel, MD, PhD
9:50am – 10:00amKeynote Address: TBDE. David Crawford, MD
10:00am – 10:20amNMIBC Trials for BCG Naive Patients: What is ExcitingJoshua J. Meeks, MD, PhD
10:20am – 10:30amEnhanced Techniques of NMIBC DetectionMark D. Tyson, II, MD, MPH
10:30am – 11:00amPanel Discussion: New Therapies for BCG Unresponsive NMIBC: Where Do We Stand?Moderator: Sam S. Chang, MD, MBADiscussants: Peter Black, MD, Jennifer A. Linehan, MD, Joshua J. Meeks, MD, PhD, Parminder Singh, MD
11:00am – 12:00pmSession III: Challenging Case PresentationsModerator: Mark D. Tyson, II, MD, MPHDiscussants: Peter Black, MD, Jennifer A. Linehan, MD, Joshua J. Meeks, MD, PhD, Parminder Singh, MD
12:00pm – 1:00pmIndustry-supported Lunch Symposium
1:00pm – 2:30pmExhibits Open
1:00pm – 2:30pmSession IV: Advanced Urothelial Cancer Part 1: Impact of ImmunotherapyModerator: Daniel P. Petrylak, MD
1:00pm – 1:10pmImmune Checkpoint InhibitorsDaniel P. Petrylak, MD
1:10pm – 1:30pmImmune Checkpoint Inhibitors: Combination TherapyJean H. Hoffman-Censits, MD
1:30pm – 1:50pmImmune Checkpoint Inhibitors: Managing Immune-related Side EffectsGuru P. Sonpavde, MD
1:50pm – 2:00pmEarlier Use of These Treatments Moving Into Adjuvant and NMIBC: What Do We Do About Patients for Reinduction of Immune TreatmentGuru P. Sonpavde, MD
2:00pm – 2:30pmPanel Discussion: Future Challenges to the Use of Immunotherapy: What’s the Right Timing and Sequencing?Moderator: Daniel P. Petrylak, MD
2:30pmAdjourn
Afternoon / EveningOn Own
Sunday, November 20, 2022 (ALL TIMES PST)
7:00am – 8:00amIndustry-supported Breakfast Symposium
7:00am – 12:30pmExhibits Open
8:00am – 9:30amSession V: Advanced Urothelial Cancer Part 2: Latest Research and Clinical TrialsModerator: Daniel P. Petrylak, MD
8:00am – 8:20amFGFR Kinase Inhibitors and Other Novel Targets in the Treatment of Metastatic Urothelial CancerParminder Singh, MD
8:20am – 8:35amThe Use of Antibody-drug Conjugates in Treating Advanced Urothelial CancerDaniel P. Petrylak, MD
8:35am – 8:50amTargeted Therapy Combined with Immune Checkpoint Therapy: Is This the Wave of the Future?Jean H. Hoffman-Censits, MD
8:50am – 9:05amBiomarker Integration for Advanced Urothelial CarcinomaDonna Hansel, MD, PhD
9:05am – 9:30amPanel Discussion / Questions and AnswersModerator: Daniel P Petrylak, MDDiscussants: Donna Hansel, MD, PhD, Jean H. Hoffman-Censits, MD, Parminder Singh, MD, Guru P. Sonpavde, MD
9:30am – 9:50amBreak and Visit Exhibits
9:50am – 10:50amSession VI: Management of UTUCModerator: Jennifer A. Linehan, MD
9:50am – 10:10amUTUC – Is it Biologically Distinct?Donna Hansel, MD, PhD
9:50am – 10:10amMethods and Guidelines to Stage and Grade (Low vs. High) UTUC and How Should We TreatSeth P. Lerner, MD
10:10am – 10:30amTreatment of Advanced UTUCJennifer A. Linehan, MD
10:30am – 10:50amPanel Discussion / Questions and AnswersModerator: Jennifer A. Linehan, MDDiscussants: Peter Black, MD, Sam S. Chang, MD, MBA, Seth P. Lerner, MD, Mark D. Tyson, II, MD, MPH
10:50am – 12:30pmSession VII: Management of MIBCModerator: Peter Black, MD
10:50am – 11:10amNeoadjuvant or Adjuvant Therapy?Parminder Singh, MD
11:10am – 11:30amWhat Should I Do About Micropapillae? Do I treat it differently than standard?Donna Hansel, MD, PhD
11:30am – 11:50amBladder Sparing Regimens for Muscle Invasive Disease: Should We Be Doing this More?Peter Black, MD
11:50am – 12:10pmUtilizing Molecular Characterization of Invasive Bladder Cancer: What It Means Now and In the FutureJoshua J. Meeks, MD, PhD
12:10pm – 12:30pmPanel Discussion / Questions and AnswersModerator: Daniel P Petrylak, MD
12:30pmClosing Remarks & Adjourn

Accommodations

The Westin Kierland Resort & Spa
6902 East Greenway Parkway
Scottsdale, Arizona 85254

Discover a refreshing oasis at The Westin Kierland Resort & Spa. Nestled in the heart of North Scottsdale’s acclaimed 730-acre master-planned Kierland community, the resort sets an unprecedented standard for offering a complimentary collection of world-class amenities at your fingertips—enjoy premier accommodations, dining, golf, and spa paired with highly sought-after shopping, eateries, and activities located just steps from the resort.

ROOM RESERVATIONS:
https://book.passkey.com/gt/218497358?gtid=c9d5ace5e207d48ba68926ee6dda65e

ROOM RATES:

  • $269.00 a night
  • $30 a night resort fee + 12.57% tax

CONFERENCE ATTIRE:
Attire is business casual. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activities.

Transportation

Ground Transportation
We suggest Uber and Lyft. Search for shuttle options or other transportation to and from the Westin Kierland Resort and Spa.

Hotel Parking:
(Pricing subject to change and inclusive of tax)

  • Gated Self-Parking
    • Short term self-parking (0-10 hours): $10.00
    • Overnight Parking: $20.00
  • Valet-Parking
    • Up to 4 Hours: $17.00
    • 4 + Hours: $35.00
    • Overnight Parking: $35.00

Activities

Golf

The Westin Kierland Golf Club presents a thoughtfully distinctive, award-winning brand of golf in which guests are consistently met with an elevated golf experience rich in innovation, one-of-a-kind offerings, and fun new ways to play its 27 Troon-managed holes.

More Information

Agave Spa & Salon

Agave, The Arizona Spa & Salon offers treatments inspired by traditional practices handed down through many of Arizona’s native cultures—paired with therapies infused with healing traditions from the best practices worldwide—to present a refined rejuvenation experience.

More Information

Pools & Waterpark

One of the resort’s biggest attractions is the Adventure Water Park, which offers the iconic Kierland FlowRider flow-board simulator for surfing in the desert, a lazy river and a 110-foot-long waterslide, and more! Rent a family-friendly poolside cabana to relax in shaded luxury or enjoy your very own Tommy Bahama Relaxation Reef private “island.” Discover a true oasis in Scottsdale.

More Information

McDowell Sonoran Preserve

This vast urban preserve encompasses more than 30,500 acres and boasts 225+ miles of scenic shared-use trails in the McDowell Mountain foothills for hiking, mountain biking, and horseback riding. One of the Preserve’s 11 trailheads, the Gateway is a great place to start your explorations. You’ll find trails for all skill levels, from the ADA-accessible Bajada Nature Trail to the calorie-busting Windgate Pass Trail.

More Information

Old Town Scottsdale

Old Town’s nine walkable neighborhoods offer you a variety of experiences by day and night. Discover Scottsdale’s beginnings in Historic Old Town, browse the galleries of the Arts District during the weekly ArtWalk, shop along Fifth Avenue or discover the energy of Scottsdale after dark in the Entertainment District.

More Information

Sonoran Desert Adventures

We may be partial, but we think Scottsdale’s great outdoors is greater than most. Our sunny skies and the lush Sonoran Desert create the perfect backdrop for outdoor adventures like hot air ballooning, horseback riding, off-road tours, river rafting, and more. And thanks to our professional guides and outfitters, there’s no experience required to enjoy the best outdoor activities in Scottsdale!

More Information

Invited Faculty

Sam S. Chang, MD, MBA

Sam S. Chang, MD, MBA

Program Co-Chair
Vanderbilt University School of Medicine
Nashville, Tennessee

Daniel P. Petrylak, MD

Daniel P. Petrylak, MD

Program Co-Chair
Yale Cancer Center
New Haven, Connecticut

Peter Black, MD

Peter Black, MD

Vancouver Prostate Centre and the University of British Columbia
Vancouver, BC, Canada

E. David Crawford, MD

E. David Crawford, MD

University of California San Diego
La Jolla, California

Donna Hansel, MD, PhD

Donna Hansel, MD, PhD

The University of Texas MD Anderson Cancer Center
Houston, Texas

Jean H. Hoffman-Censits, M.D.

Jean H. Hoffman-Censits, M.D.

Johns Hopkins Medicine
Baltimore, Maryland

Seth P. Lerner, MD

Seth P. Lerner, MD

Baylor College of Medicine
Houston, TX

Jennifer A. Linehan, MD

Jennifer A. Linehan, MD

Providence Saint John’s Health Center
Santa Monica, California

Joshua J. Meeks, MD, PhD

Joshua J. Meeks, MD, PhD

Northwestern University
Chicago, Illinois

Parminder Singh, MD

Parminder Singh, MD

Mayo Clinic
Phoenix, Arizona

Guru P. Sonpavde, MD

Guru P. Sonpavde, MD

AdventHealth Cancer Institute
Orlando, Florida

C.J. Stimson, MD, JD

C.J. Stimson, MD, JD

Vanderbilt University Medical Center
Nashville, Tennessee

Mark D. Tyson, II, MD, MPH

Mark D. Tyson, II, MD, MPH

Mayo Clinic
Phoenix, Arizona

CME Information

This activity is approved for 9 AMA PRA Category 1 Credits

Registration

By registering for this conference, you agree to our standard Conference Registration and Attendance Terms and Conditions agreement, which is available online at: Conference Registration and Attendance Terms and Conditions.

REGISTRATION NOTES:

  • If using, the promo code goes at the top left before the ticket list.
  • Please scroll through all the ticket options before making a selection.
  • Review the form before submitting it to make sure that all required information is supplied.

COVID-19 DISCLAIMER: An inherent risk of exposure to COVID-19 and other more common contagions exists in any public place where people are present. COVID-19 is an extremely contagious disease that can lead to severe illness and even death in a small percentage of the population, especially those with weakened immune systems. For your safety and convenience, we are endeavoring to take appropriate precautions, as detailed above. Even with our best efforts, however, there is no guarantee that you can avoid exposure to COVID-19 or other common pathogens, whether at our conference or elsewhere. Please note that, as further detailed in our Conference Registration and Attendance Terms and Conditions Agreement (the “Registration Agreement”), which must be reviewed and agreed to during the registration process, all conference attendees voluntarily assume ALL RISKS related to any possible exposure to COVID-19. We encourage you to read the Registration Agreement carefully, as it contains other important terms, including other disclaimers and limitations on liability.

Abstract Submission

1. When is the abstract submission deadline?
October 21, 2022

2. What are the submission guidelines?
When submitting your abstract, please follow these formatting guidelines:

  1. Include a title
  2. Maximum of 500 words
  3. Single-spaced
  4. 10-point font
  5. Times New Roman
  6. Author names must be spelled out
  7. List the institution, city, state, country, and e-mail address of the presenting author
  8. To submit your abstract, e-mail your document to David Utz at dutz@cjp.com and Greg Donohue at gdonohue@cjp.com.

3. How will the posters be displayed?
After your abstract is submitted and approved, please send a recording (3 minutes or shorter, MP4 or MOV format) to gdonohue@cjp.com of someone presenting the poster. This is usually done by an author of the abstract, but is not required. Zoom has an easy self-recording option with screen share for the abstract slides. Please also send bio information about the presenter of the abstract.

4. Who can give the oral poster presentation?
Anyone involved with the poster; does not need to be a lead investigator or healthcare provider. However, please provide the name of the presenter to us in advance, by October 31, 2022, if possible.

5. Are the poster sessions CME accredited?
No

6. I have other questions, who can I contact?
Greg at gdonohue@cjp.com

NOTE: The abstract will also be printed in an abstract book. Along with the abstract slide image itself, text similar to the following will be printed in the abstract book:

Support Opportunities

To inquire about support opportunities, please contact:

Marc Weathersby, Chief Commercial Officer
Tel:434-817-2000, x193    Cell: 434-989-5508
Fax 434-817-2020    mweathersby@cjp.com

Exhibit and Sponsor Prospectus

Meeting organized by Grand Rounds in Urology, a division of Carden Jennings Publishing, Co., Ltd.

Jointly provided by Medical Education Resources and Carden Jennings Publishing Co., Ltd.

View content from previous International Bladder Cancer Update meetings